Table 2.

Single nucleotide polymorphism analyzed in 44 nonvascular AMD patients.

Gene	SNP	Base changea	Total frequency (%)	Frequency of homozygous common allele	Frequency of heterozygous allele	Frequency of homozygous rare allele
CFH	rs203674	C→A	90.90%	0.365	0.414	0.219
CFH	rs572515	T→C	93.18%	0.341	0.414	0.243
CFH	rs800292	C→A	77.27%	0.735	0.26	0
CFH	rs1061147	A→C	100%	0.509	0.372	0.117
CFH	rs1061170	C→T	70.45%	0.387	0.483	0.129
CFH	rs2274700	C→T	95.45%	0.547	0.285	0.166
CFH	rs7529589	T→C	88.63%	0.358	0.512	0.128
CFH	rs12038333	G→A	90.90%	0.35	0.45	0.2
CFH	rs35507625	del	93.18%	0.829	0.121	0.04
LOC387715/ARMS2	rs11200638	A→G	63.63%	0.5	0.357	0.142
LOC387715/ARMS2	rs10664316	Del AT	86.36%	0.552	0.342	0.105
HTRA1	rs2672598	G→A	52.27%	0.565	0.434	0

CFH = complement factor H gene, ARMS2 = age-related maculopathy susceptibility 2 gene, HTRA1 = HtrA serine peptidase 1 gene, SNP = single nucleotide polymorphism.

^aBase change is written common allele > rare allele.